Compare OBIO & QNBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBIO | QNBC |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 253.9M | 281.3M |
| IPO Year | 2020 | 1996 |
| Metric | OBIO | QNBC |
|---|---|---|
| Price | $6.10 | $45.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $14.25 | N/A |
| AVG Volume (30 Days) | ★ 303.9K | 9.9K |
| Earning Date | 05-11-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.13 | 21.15 |
| EPS | N/A | ★ 1.32 |
| Revenue | ★ $33,482,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.43 | N/A |
| P/E Ratio | ★ N/A | $34.71 |
| Revenue Growth | ★ 1169.22 | N/A |
| 52 Week Low | $2.50 | $44.75 |
| 52 Week High | $6.48 | $45.94 |
| Indicator | OBIO | QNBC |
|---|---|---|
| Relative Strength Index (RSI) | 57.56 | 63.58 |
| Support Level | $5.71 | $45.45 |
| Resistance Level | $6.48 | $45.92 |
| Average True Range (ATR) | 0.36 | 0.30 |
| MACD | -0.05 | 0.07 |
| Stochastic Oscillator | 23.12 | 89.50 |
Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.
QNB Corp is a bank holding company based in the United States. It operates through its wholly-owned subsidiary, which engages in the general commercial banking business and offers a full range of banking services to its customers. Its business activities involve attracting deposits and using funds in making commercial loans, residential mortgage loans, consumer loans, and purchasing investment securities. The loan portfolio includes commercial loans, such as commercial and industrial, construction, and loans secured by commercial real estate and residential real estate, and retail loans, including home equity loans and lines, and consumer loans. It generates revenue from net interest income.